India's Orchid Pharma hits upper circuit on nod to antibiotic in Europe

Orchid Pharma

30/01/2024 05:35

** Shares of Orchid Pharma  ORCD.NS  hit upper circuit, up
20% at 863.85 rupees
    ** Stock set for best day since Sept. 21, 2017, if trend
holds
    ** Drugmaker gets European Medicines Agency approval for
antibiotic 'Exblifep'
    ** Stock sees busiest day since Dec. 8 when brokerage
Investec initiated coverage of co

 (Reporting by Varun Vyas in Bengaluru)
 ((varunvyas.hebbalalu@thomsonreuters.com))